Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Catastrophic antiphospholipid syndrome: CAPS].

Masahide Yamazaki1

  • 1Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine, Division of Hematology.

Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|January 6, 2006
PubMed
Summary

Catastrophic antiphospholipid syndrome (CAPS) is a severe condition. Immunoadsorption plasmapheresis (IAPP) effectively improved symptoms and reduced antiphospholipid antibodies in 5 CAPS patients, suggesting it as a promising treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mirogabalin efficacy and safety for chemotherapy-induced peripheral neuropathy: single-centre retrospective observational study.

BMJ supportive & palliative care·2025
Same author

Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.

British journal of haematology·2025
Same author

Retreatment with brentuximab vedotin for discordant peripheral T-cell lymphomas.

Leukemia research reports·2025
Same author

Nephrotic syndrome with rectus sheath hematoma: a case report.

Journal of medical case reports·2024
Same author

Cryoglobulinemia vasculitis associated with adult-onset Still's disease.

Clinical case reports·2024
Same author

Inflammation and malnutrition as markers of poor outcomes in head and neck cancer patients treated with nivolumab.

Acta oto-laryngologica·2023

Area of Science:

  • Autoimmune diseases
  • Hematology
  • Immunology

Context:

  • Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent thromboses.
  • Catastrophic antiphospholipid syndrome (CAPS) is a severe variant involving microvascular thrombosis and poor prognosis.
  • Current CAPS treatments, including plasma exchange, anticoagulation, and immunosuppression, are not fully established.

Purpose:

  • To evaluate the efficacy of immunoadsorption plasmapheresis (IAPP) as a treatment for catastrophic antiphospholipid syndrome (CAPS).

Summary:

  • This study treated 5 CAPS patients with immunoadsorption plasmapheresis (IAPP).
  • Patients showed improvement in clinical symptoms and a reduction in antiphospholipid antibody titers.
  • IAPP demonstrated potential as a therapeutic option for CAPS.

Related Experiment Videos

Impact:

  • Immunoadsorption plasmapheresis (IAPP) may offer a new treatment strategy for catastrophic antiphospholipid syndrome (CAPS).
  • Further prospective studies are warranted to confirm the efficacy and long-term benefits of IAPP in CAPS management.